Tea Flavonoids: Bioavailability In Vivo and Effects on Cell Signaling Pathways In Vitro
- 1 December 2001
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 3 (6) , 1009-1021
- https://doi.org/10.1089/152308601317203549
Abstract
The elucidation of the potential health benefits of tea beverage continues to be a focus of research in many laboratories. Beneficial effects of tea have been particularly evident in animal tumorigenesis models, with green and black tea frequently demonstrating similar effectivity. Human data are now emerging to support a beneficial role for tea in cardiovascular disease, but the data with respect to cancer risk at various sites remain inconclusive. The constituent flavonoids of green and black tea beverage are known to be potent antioxidants, and although this may be a major factor in explaining their biological activity, it appears that the gallated flavonoids in particular (e.g., epigallocatechin gallate and the gallated theaflavins) impact on a wide range of molecular targets that influence cell growth and more specifically pathways such as those involving angiogenesis. Data on the pharmacokinetic properties of tea flavonoids, primarily on the catechins and therefore related most closely to green tea, have provided indications of the plasma levels and circulating molecular forms that may be expected in humans following tea consumption. The structural complexity of black tea flavonoids, in particular the thearubigins, has hindered efforts to describe their bioavailability and to perform mechanistic studies. Recent studies on the effects of catechins and theaflavins on growth factor-, nuclear factor-κB-, and stress-mediated signal transductions are described in this review, where possible in relation to their bioavailability in vivo. These studies indicate that effects that may be relevant to both cancer and atherosclerosis are often observed at tea flavonoid levels that could realistically be encountered in vivo. However, more studies need to be performed using those molecular forms of tea flavonoids (methylated, sulfated, and glucuronidated conjugates) that are the major circulating species encountered following tea consumption. Such studies, combined with further human epidemiological and interventional data, should ultimately elucidate the full beneficial potential of tea beverage on human health.Keywords
This publication has 57 references indexed in Scilit:
- Cell Cycle Dysregulation by Green Tea Polyphenol Epigallocatechin-3-GallateBiochemical and Biophysical Research Communications, 2000
- Inhibition of Ultraviolet B–Induced AP‐1 Activation by Theaflavins From Black TeaMolecular Carcinogenesis, 2000
- Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastomaFEBS Letters, 2000
- Inhibition of cyclin‐dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)‐epigallocatechin‐3‐gallateJournal of Cellular Biochemistry, 1999
- Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma CellsJNCI Journal of the National Cancer Institute, 1997
- Tea flavonoids and cardiovascular diseases: A reviewCritical Reviews in Food Science and Nutrition, 1997
- Inhibition of carcinogenesis by tea: The evidence from experimental studiesCritical Reviews in Food Science and Nutrition, 1997
- Antioxidants in teaCritical Reviews in Food Science and Nutrition, 1997
- The chemistry of tea flavonoidsCritical Reviews in Food Science and Nutrition, 1997
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980